PIRAMAL CRITICAL FDA Approval ANDA 214794

ANDA 214794

PIRAMAL CRITICAL

FDA Drug Application

Application #214794

Application Sponsors

ANDA 214794PIRAMAL CRITICAL

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 200MCG BASE/2ML (EQ 100MCG BASE/ML)0DEXMEDETOMIDINE HYDROCHLORIDEDEXMEDETOMIDINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2021-09-03STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

PIRAMAL CRITICAL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214794
            [companyName] => PIRAMAL CRITICAL
            [docInserts] => ["",""]
            [products] => [{"drugName":"DEXMEDETOMIDINE HYDROCHLORIDE","activeIngredients":"DEXMEDETOMIDINE HYDROCHLORIDE","strength":"EQ 200MCG BASE\/2ML (EQ 100MCG BASE\/ML)","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/03\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-09-03
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.